↓ Skip to main content

Dove Medical Press

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel

Overview of attention for article published in Cancer Management and Research, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
123 Mendeley
Title
Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel
Published in
Cancer Management and Research, December 2013
DOI 10.2147/cmar.s52256
Pubmed ID
Authors

René-Jean Bensadoun, Phillipe Humbert, Jean Krutman, Thomas Luger, Raoul Triller, André Rougier, Sophie Seite, Brigitte Dreno

Abstract

Skin reactions due to radiotherapy and chemotherapy are a significant problem for an important number of cancer patients. While effective for treating cancer, they disturb cutaneous barrier function, causing a reaction soon after initiation of treatment that impacts patient quality of life. Managing these symptoms with cosmetics and nonpharmaceutical skin care products for camouflage or personal hygiene may be important for increasing patient self-esteem. However, inappropriate product choice or use could worsen side effects. Although recommendations exist for the pharmaceutical treatment of skin reactions, there are no recommendations for the choice or use of dermatologic skin care products for oncology patients. The present guidelines were developed by a board of European experts in dermatology and oncology to provide cancer care professionals with guidance for the appropriate use of non-pharmaceutical, dermocosmetic skin care management of cutaneous toxicities associated with radiotherapy and systemic chemotherapy, including epidermal growth factor inhibitors and monoclonal antibodies. The experts hope that these recommendations will improve the management of cutaneous side effects and hence quality of life for oncology patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Unknown 122 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 11%
Student > Bachelor 12 10%
Student > Doctoral Student 11 9%
Researcher 9 7%
Other 7 6%
Other 28 23%
Unknown 43 35%
Readers by discipline Count As %
Medicine and Dentistry 40 33%
Nursing and Health Professions 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Agricultural and Biological Sciences 7 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 11 9%
Unknown 46 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2023.
All research outputs
#3,035,400
of 24,004,724 outputs
Outputs from Cancer Management and Research
#90
of 2,012 outputs
Outputs of similar age
#35,220
of 315,475 outputs
Outputs of similar age from Cancer Management and Research
#1
of 5 outputs
Altmetric has tracked 24,004,724 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,012 research outputs from this source. They receive a mean Attention Score of 3.3. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,475 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them